Device Week – October 17, 2016
On this week's podcast, we discussed trends and challenges with adverse-event reporting in the US, lab-developed test marketing, some companion diagnostic data and a look ahead to this week's AdvaMed conference in Minneapolis.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.